Marinus Presents Additional Data from Ganaxolone Phase 2 Trial in Refractory Status Epilepticus at the American Epilepsy Society Annual Meeting
Stock Information for Marinus Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.